Search Within

Marinela Capanu

Formats
  1. Journal Article (228)
  2. Meeting Abstract (155)
  3. Correspondence (3)
  4. Miscellaneous (1)
Groups
  1. Biostatistics Service (387)
  2. Center for Pancreatic Cancer Research (387)
  3. Epidemiology and Biostatistics (387)
  4. Department of Medicine (310)
  5. Solid Tumor Oncology Division (307)
  6. Gastrointestinal Oncology Service (277)

More Groups

People
  1. Joanne Chou (164)
  2. David Kelsen (98)
  3. Eileen O'Reilly (94)
  4. David Ilson (65)
  5. Ghassan Abou-Alfa (65)
  6. Yelena Janjigian (61)

More People

Years
  1. 2025 (10)
  2. 2024 (23)
  3. 2023 (21)
  4. 2022 (24)
  5. 2021 (24)
  6. 2020 (25)

More Years

Publications
  1. Journal of Clinical Oncology (145)
  2. Cancer (18)
  3. Abdominal Radiology (14)
  4. Annals of Oncology (14)
  5. Clinical Cancer Research (12)
  6. Annals of Surgical Oncology (11)

More Publications

Publishers
  1. American Society of Clinical Oncology (150)
  2. Springer (40)
  3. Wiley Blackwell (31)
  4. Oxford University Press (27)
  5. Elsevier Inc. (22)
  6. Lippincott Williams & Wilkins (21)

More Publishers

Results (387)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Variation of breast cancer risk among BRCA1/2 carriers
    Journal Article

    Begg, C. B.; Haile, R. W.; Borg, A.; Malone, K. E.; Concannon, P.; Thomas, D. C.; Langholz, B.; Bernstein, L.; Olsen, J. H.; Lynch, C. F.; more...
    JAMA - Journal of the American Medical Association (2008)

    Fulltext@MSK | Save
  • Pharmacogenomic analysis of a randomized phase II trial (BOND 2) of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer
    Meeting Abstract

    Zhang, W.; Yang, D.; Capanu, M.; Hollywood, E.; Lue-Yat, M.; Borucka, E.; Azuma, M.; Gordon, M.; Saltz, L.; Lenz, H.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Is neoadjuvant (neoadj) treatment necessary prior to liver resection in patients with resectable liver metastases (mets) from colorectal carcinoma (CRC) treated with post-resection hepatic arterial infusion (HAI) plus systemic (SYS) chemotherapy
    Meeting Abstract

    Kemeny, N. E.; Capanu, M.; Huitzil-Melendez, F.; Haviland, D.; Fong, Y.; Jarnagin, W.; Blumgart, L.; DeMatteo, R.; D'Angelica, M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Prognostic factors (PF) in advanced hepatocellular carcinoma (AHCC): Multivariate analysis and comparison between staging systems (SS) in patients (pts) treated at Memorial Sloan-Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Huitzil, F. D.; Capanu, M.; Jacobs, G.; Smith, W.; O'Reilly, E.; Shah, M.; Schwartz, G. K.; Saltz, L. B.; Kelsen, D. P.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC)
    Meeting Abstract

    Duffy, A.; Capanu, M.; Abou-Alfa, G. K.; Huitzel, D.; Williams, P.; Jarnagin, W.; Fong, Y.; Kelsen, D. P.; O'Reilly, E. M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Incidence and significance of thromboembolic events (TE) in patients with gastrointestinal (GI) and non-GI malignancies on systemic cytotoxic therapy
    Meeting Abstract

    Asmis, T. R.; Templeton, M.; Trocola, R.; Pincus, N.; Randazzo, J.; Marinela, C.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Molecular markers associated with response and clinical outcome to cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer (BOND2)
    Meeting Abstract

    Azuma, M.; Yang, D.; Carpanu, M.; Hollywood, E.; Lue-Yat, M.; Zhang, W.; Danenberg, K. D.; Danenberg, P. V.; Saltz, L.; Lenz, H.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy
    Journal Article

    Lassmann, S.; Tang, L.; Capanu, M.; Brabletz, T.; Schöpflin, A.; Zur Hausen, A.; Gonen, M.; Kemeny, N.; Shia, J.; Klimstra, D.; more...
    Gastroenterology (2007)

    Fulltext@MSK | Save
  • Reproductive history and risk of second primary breast cancer: The WECARE study
    Journal Article

    Largent, J. A.; Capanu, M.; Bernstein, L.; Langholz, B.; Mellemkjaer, L.; Malone, K. E.; Begg, C. B.; Haile, R. W.; Lynch, C. F.; Anton-Culver, H.; more...
    Cancer Epidemiology Biomarkers and Prevention (2007)

    Fulltext@MSK | Save
  • Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: A retrospective analysis
    Journal Article

    Gallagher, D. J.; Capanu, M.; Raggio, G.; Kemeny, N.
    Annals of Oncology (2007)

    Fulltext@MSK | Save